Manufacturer:

Actavis

Name:

Fosaprepitant

HCPCS Code Descriptor:

Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg

Category:

J Code

HCPCS:

J1456

NDC(s):

00591-4385-79,

Primary Type:

Oncology-Anti-Emetic

Route of Administration:

Intravenous

About:

Fosaprepitant is an Oncology-Anti-Emetic drug manufactured by Actavis and administered via the Intravenous route of administration. The J Code: J1456 is aligned to the drug Fosaprepitant.

Patient Assistance: